Secukinumab Therapy in Refractory Juvenile Idiopathic Arthritis

Juvenile idiopathic arthritis (JIA), the most common chronic rheumatologic condition in childhood, remains a cause of significant morbidity, particularly in those with spondyloarthropathy, including psoriatic arthritis (PsA) and enthesitis-related arthritis (ERA). While secukinumab was recently appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Meghan Corrigan, Manos, Cynthia K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515513/
https://www.ncbi.nlm.nih.gov/pubmed/37731263
http://dx.doi.org/10.1177/23247096231200403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515513/
https://www.ncbi.nlm.nih.gov/pubmed/37731263
http://dx.doi.org/10.1177/23247096231200403

Ejemplares similares